Steven M. Greenberg, MD, PhD, FAHA, Chair; Wendy C. Ziai, MD, MPH, FAHA, Vice Chair;
Charlotte Cordonnier, MD, PhD; Dar Dowlatshahi, MD, PhD, FAHA; Brandon Francis, MD …

SVD is the leading cause of VCI and is associated with substantial morbidity. Tackling
cardiovascular risk factors is currently the most effective approach to prevent cognitive …

Importance Cerebral amyloid angiopathy–related inflammation (CAA-ri), a distinct subtype of
cerebral amyloid angiopathy, is characterized by an autoimmune reaction to …

Objective To assess the association of cortical superficial siderosis (cSS) presence and
extent with future bleeding risk in cerebral amyloid angiopathy (CAA). Methods This was a …

Background and purpose Cerebral amyloid angiopathy (CAA) is characterized by β‐amyloid
deposition in cortical and leptomeningeal arterioles, which might result from glymphatic …

Background Findings from the RESTART trial suggest that starting antiplatelet therapy might
reduce the risk of recurrent symptomatic intracerebral haemorrhage compared with avoiding …

Background: Limited data exist regarding the prevalence of clinical and neuroimaging
manifestations among patients diagnosed with cerebral amyloid angiopathy (CAA). We …

Background Patients with spontaneous intracerebral hemorrhage (ICH) have a higher risk of
venous thromboembolism (VTE) and in-hospital VTE is independently associated with poor …

Background: Intracerebral hemorrhage (ICH) recurrence risk is known to be higher in
patients with cerebral amyloid angiopathy (CAA) as compared to other causes of ICH. Risk …

Background and Objectives In patients with lobar intracerebral hemorrhage (ICH), etiologic
characterization represents a tradeoff between feasibility, resource allocation, and …